Hamilton Wealth LLC Makes New $4.85 Million Investment in iShares Biotechnology ETF $IBB

Hamilton Wealth LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 33,587 shares of the financial services provider’s stock, valued at approximately $4,849,000. iShares Biotechnology ETF comprises approximately 1.0% of Hamilton Wealth LLC’s portfolio, making the stock its 28th biggest holding. Hamilton Wealth LLC owned approximately 0.08% of iShares Biotechnology ETF at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $25,000. Financial Gravity Companies Inc. bought a new stake in iShares Biotechnology ETF in the second quarter valued at approximately $29,000. Ashton Thomas Securities LLC bought a new stake in iShares Biotechnology ETF in the third quarter valued at approximately $36,000. Parkside Financial Bank & Trust lifted its position in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after buying an additional 87 shares during the last quarter. Finally, Close Asset Management Ltd lifted its position in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock valued at $50,000 after buying an additional 70 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.4%

Shares of NASDAQ IBB opened at $165.51 on Monday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64. The stock has a 50 day moving average of $172.69 and a 200-day moving average of $162.72.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.